168 related articles for article (PubMed ID: 37950038)
1. LncRNA MIR31HG fosters stemness malignant features of non-small cell lung cancer via H3K4me1- and H3K27Ace-mediated GLI2 expression.
Chen W; Wang F; Yu X; Qi J; Dong H; Cui B; Zhang Q; Wu Y; An J; Ni N; Liu C; Han Y; Zhang S; Schmitt CA; Deng J; Yu Y; Du J
Oncogene; 2024 May; 43(18):1328-1340. PubMed ID: 37950038
[TBL] [Abstract][Full Text] [Related]
2. MIR31HG promotes cell proliferation and invasion by activating the Wnt/β-catenin signaling pathway in non-small cell lung cancer.
Zheng S; Zhang X; Wang X; Li J
Oncol Lett; 2019 Jan; 17(1):221-229. PubMed ID: 30655759
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of lncRNA MIR31HG in melanoma.
Xu HL; Tian FZ
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4389-4395. PubMed ID: 32373976
[TBL] [Abstract][Full Text] [Related]
4. The predictive value of lncRNA MIR31HG expression on clinical outcomes in patients with solid malignant tumors.
Tu C; Ren X; He J; Li S; Qi L; Duan Z; Wang W; Li Z
Cancer Cell Int; 2020; 20():115. PubMed ID: 32280307
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of lncRNA MIR31HG correlated with aggressive clinicopathological features and unfavorable prognosis in esophageal squamous cell carcinoma.
Ren ZP; Chu XY; Xue ZQ; Zhang LB; Wen JX; Deng JQ; Hou XB
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3866-3870. PubMed ID: 28975978
[TBL] [Abstract][Full Text] [Related]
6. Increased MIR31HG lncRNA expression increases gefitinib resistance in non-small cell lung cancer cell lines through the EGFR/PI3K/AKT signaling pathway.
Wang B; Jiang H; Wang L; Chen X; Wu K; Zhang S; Ma S; Xia B
Oncol Lett; 2017 May; 13(5):3494-3500. PubMed ID: 28529576
[TBL] [Abstract][Full Text] [Related]
7. A Positive Feedback Loop of lncRNA MIR31HG-miR-361-3p -YY1 Accelerates Colorectal Cancer Progression Through Modulating Proliferation, Angiogenesis, and Glycolysis.
Guo T; Liu D; Peng S; Wang M; Li Y
Front Oncol; 2021; 11():684984. PubMed ID: 34485123
[TBL] [Abstract][Full Text] [Related]
8. A novel cuproptosis-related prognostic lncRNA signature and lncRNA MIR31HG/miR-193a-3p/TNFRSF21 regulatory axis in lung adenocarcinoma.
Mo X; Hu D; Yang P; Li Y; Bashir S; Nai A; Ma F; Jia G; Xu M
Front Oncol; 2022; 12():927706. PubMed ID: 35936736
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA MIR31HG is activated by SP1 and promotes cell migration and invasion by sponging miR-214 in NSCLC.
Dandan W; Jianliang C; Haiyan H; Hang M; Xuedong L
Gene; 2019 Apr; 692():223-230. PubMed ID: 30659947
[TBL] [Abstract][Full Text] [Related]
10. LncRNA MIR31HG overexpression serves as poor prognostic biomarker and promotes cells proliferation in lung adenocarcinoma.
Qin J; Ning H; Zhou Y; Hu Y; Yang L; Huang R
Biomed Pharmacother; 2018 Mar; 99():363-368. PubMed ID: 29367106
[TBL] [Abstract][Full Text] [Related]
11. Decreased long noncoding RNA MIR31HG is correlated with poor prognosis and contributes to cell proliferation in gastric cancer.
Nie FQ; Ma S; Xie M; Liu YW; De W; Liu XH
Tumour Biol; 2016 Jun; 37(6):7693-701. PubMed ID: 26692098
[TBL] [Abstract][Full Text] [Related]
12. Suppression of MIR31HG affects the functional properties of thyroid cancer cells depending on the miR-761/MAPK1 axis.
Peng S; Chen L; Yuan Z; Duan S
BMC Endocr Disord; 2022 Apr; 22(1):107. PubMed ID: 35443670
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression.
Yan S; Tang Z; Chen K; Liu Y; Yu G; Chen Q; Dang H; Chen F; Ling J; Zhu L; Huang A; Tang H
J Exp Clin Cancer Res; 2018 Sep; 37(1):214. PubMed ID: 30176933
[TBL] [Abstract][Full Text] [Related]
14. MIR31HG Expression Predicts Poor Prognosis and Promotes Colorectal Cancer Progression.
Wang J; Liu B; Cao J; Zhao L; Wang G
Cancer Manag Res; 2022; 14():1973-1986. PubMed ID: 35733512
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA MIR31HG abrogates the availability of tumor suppressor microRNA-361 for the growth of osteosarcoma.
Sun Y; Jia X; Wang M; Deng Y
Cancer Manag Res; 2019; 11():8055-8064. PubMed ID: 31564967
[TBL] [Abstract][Full Text] [Related]
16. LncRNA MIR31HG targets HIF1A and P21 to facilitate head and neck cancer cell proliferation and tumorigenesis by promoting cell-cycle progression.
Wang R; Ma Z; Feng L; Yang Y; Tan C; Shi Q; Lian M; He S; Ma H; Fang J
Mol Cancer; 2018 Nov; 17(1):162. PubMed ID: 30458787
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of LncRNA MIR31HG in human bladder cancer.
He A; Chen Z; Mei H; Liu Y
Cancer Biomark; 2016 Jul; 17(2):231-6. PubMed ID: 27434291
[TBL] [Abstract][Full Text] [Related]
18. Significance of lncRNA
Zhou Y; Fan Y; Zhou X; Mou A; He Y; Wang F; Liu Y
Biomark Med; 2020 Mar; 14(4):303-316. PubMed ID: 32134327
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer.
Wu S; Nitschke K; Worst TS; Fierek A; Weis CA; Eckstein M; Porubsky S; Kriegmair M; Erben P
J Exp Clin Cancer Res; 2020 Dec; 39(1):288. PubMed ID: 33334367
[TBL] [Abstract][Full Text] [Related]
20. MIR31HG regulates the proliferation, migration and invasion of breast cancer by regulating the expression of POLDIP2.
Xin C; Bi X; Xiao C; Dong L
J BUON; 2021; 26(2):459-465. PubMed ID: 34076993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
